跳至主要内容
临床试验/NL-OMON55916
NL-OMON55916尚未招募不适用

Alterations in microcirculatory oxygenation in long-COVID - MICROX long-COVID

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 106 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
106

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Long-COVID patients
  • Age >= 18 years, <65 years
  • Past COVID-19 diagnosis, based on
  • o Positive PCR
  • o Positive Sars-Cov2 serology
  • o Positive rapid antigen test
  • o Typical clinical syndrome during the first pandemic wave, when testing was
  • not possible
  • Long-COVID-19 diagnosis based on World Health Organisation consensus
  • diagnosis: (*Post COVID-19 condition occurs in individuals with a history of
  • probable or confirmed SARS CoV-2 infection, usually 3 months from the onset of
  • COVID-19 with symptoms and that last for at least 2 months and cannot be
  • explained by an alternative diagnosis. Symptoms may be new onset following
  • initial recovery from an acute COVID-19 episode or persist from the initial
  • illness. Symptoms may also fluctuate or relapse over time)*
  • Overall functioning <70% compared to functioning prior to onset of
  • Long-COVID/ COVID-19 infection
  • Long COVID duration > 6 months
  • Presence of post-exertional malaise
  • Provided written informed consent
  • Convalescent Controls
  • Age >= 18 years, <65 years
  • Past COVID-19 diagnosis, based on
  • o Positive PCR
  • o Positive Sars-Cov2 serology
  • o Positive rapid antigen test
  • o Typical clinical syndrome during the first pandemic wave, when testing was
  • not possible
  • No diagnosis of long-COVID, good recovery. Overall functioning >95% compared
  • to functioning prior COVID-19 infection
  • Self-reported general good wellbeing
  • Provided written informed consent

排除标准

  • Long-COVID patients
  • Unable or not willing to provide written informed consent
  • Unable to complete written questionnaires in Dutch
  • Unable to draw blood for study purposes
  • Diagnosis of dementia
  • Active treatment with hyperbaric oxygen treatment during study start
  • Alternative diagnosis that may explain clinical symptoms
  • Suffering from any pre-existing immune-driven disease or use of
  • anti-inflammatory therapy of any kind (including NSAIDs and steroids) during
  • the last 3 months
  • Suffering from diabetes mellitus, hypertension, severe mental conditions or
  • use of anticoagulant treatment in the past 4 weeks.
  • No re-infection with COVID-19 in the past 3 months
  • Convalescent Controls
  • Unable or not willing to provide written informed consent
  • Unable to complete written questionnaires in Dutch
  • Unable to draw blood for study purposes
  • Diagnosis of dementia
  • Genetically related to participating patients (e.g. brother/sister/parent)
  • Suffering from any immune-driven disease or use of anti-inflammatory therapy
  • of any kind (including NSAIDs and steroids), including during the last 3 months
  • Suffering from diabetes mellitus, hypertension, severe mental conditions or
  • use of anticoagulant treatment in the past 4 weeks.
  • Re-infection with SARS-CoV-2 in the past 3 months.

研究者

相似试验